Mirela Mircea
Family Medicine · Alexandria, VANPI 1861593931
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 304 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,398 and has fallen 98.5% since, to $21 in 2025. Among family medicine clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 304 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$704
- Novo Nordisk$686
- Lilly USA, LLC$640
- Merck$379
- Sanofi-aventis U.S. LLC$231
- plus $2K from 32 others
What the payments were for
- Food & beverage$5,488100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $1,178 |
| AstraZeneca | 38 | $704 |
| Novo Nordisk | 39 | $686 |
| Lilly USA, LLC | 36 | $640 |
| Merck | 29 | $379 |
| Sanofi-aventis U.S. LLC | 15 | $231 |
| Boehringer Ingelheim | 11 | $187 |
| GSK | 10 | $164 |
| Johnson & Johnson(2 entities) | 6 | $140 |
| Bayer | 6 | $125 |
| Abbott | 5 | $103 |
| Pfizer | 5 | $84 |
| Vanda Pharmaceuticals Inc. | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Gilead | 4 | $70 |
| Sanofi Pasteur Inc. | 4 | $64 |
| Amarin Pharma, Inc. | 3 | $62 |
| Dermira, Inc. | 3 | $49 |
| Amgen | 2 | $48 |
| Cranial Technologies, Inc | 3 | $47 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| Neos Therapeutics, LP | 2 | $32 |
| Astellas Pharma US Inc | 2 | $30 |
| Oxford Immunotec USA Inc | 1 | $27 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Renovia Inc | 1 | $24 |
| Organon | 1 | $21 |
| Exact Sciences | 1 | $21 |
| Seqirus USA Inc | 1 | $20 |
| Shield Therapeutics Inc | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Medtronic | 1 | $16 |
| Sanofi | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $12 |
| Eyevance Pharmaceuticals LLC | 1 | $12 |
How this compares
$5,499 in reported general payments places this provider in the 90th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Donepezil Hcl | 12 | $1,066 |
| Atorvastatin Calcium | 14 | $747 |
| Buspirone Hcl | 13 | $533 |
| Potassium Chloride | 11 | $192 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Alexandria
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
- John ClayColonial Heights$40K
- Thomas RobesonNewport News$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.